Compounds > pravastatin
Page last updated: 2024-08-23

pravastatin and dalcetrapib

pravastatin has been researched along with dalcetrapib in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (33.33)29.6817
2010's2 (66.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
de Grooth, GJ; Kastelein, JJ; Kawamura, H; Klerkx, AH; Kuivenhoven, JA; Trip, MD; Wilhelm, F1
Abt, M; Bech, N; Derks, M; Meneses-Lorente, G; Parr, G; Phelan, M; Turnbull, L; White, AM1
Ballantyne, CM; Burgess, T; Kallend, D; Miller, M; Niesor, EJ; Stein, EA1

Trials

3 trial(s) available for pravastatin and dalcetrapib

ArticleYear
Effectiveness of inhibition of cholesteryl ester transfer protein by JTT-705 in combination with pravastatin in type II dyslipidemia.
    The American journal of cardiology, 2005, May-01, Volume: 95, Issue:9

    Topics: Amides; Carrier Proteins; Cholesterol Ester Transfer Proteins; Cholesterol, HDL; Double-Blind Method; Drug Therapy, Combination; Esters; Female; Glycoproteins; Humans; Hyperlipidemias; Hypolipidemic Agents; Male; Middle Aged; Placebos; Pravastatin; Sulfhydryl Compounds; Treatment Outcome

2005
Coadministration of dalcetrapib with pravastatin, rosuvastatin, or simvastatin: no clinically relevant drug-drug interactions.
    Journal of clinical pharmacology, 2010, Volume: 50, Issue:10

    Topics: Adult; Amides; Anticholesteremic Agents; Area Under Curve; Cholesterol Ester Transfer Proteins; Cholesterol, HDL; Cholesterol, LDL; Cross-Over Studies; Drug Interactions; Drug Therapy, Combination; Esters; Fluorobenzenes; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Pravastatin; Pyrimidines; Rosuvastatin Calcium; Simvastatin; Sulfhydryl Compounds; Sulfonamides

2010
Effect of dalcetrapib plus pravastatin on lipoprotein metabolism and high-density lipoprotein composition and function in dyslipidemic patients: results of a phase IIb dose-ranging study.
    American heart journal, 2012, Volume: 163, Issue:3

    Topics: Adolescent; Adult; Aged; Amides; Anticholesteremic Agents; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Dyslipidemias; Electrophoresis, Polyacrylamide Gel; Esters; Female; Follow-Up Studies; Humans; Lipoproteins, HDL; Magnetic Resonance Spectroscopy; Male; Middle Aged; Pravastatin; Sulfhydryl Compounds; Treatment Outcome; Young Adult

2012